Facing Eating Disorder Fears for Anorexia Nervosa
(FED-F Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment called FED-F, designed to help people with anorexia nervosa confront fears related to food, body image, and social situations. The researchers aim to determine if FED-F is more effective than standard care after a patient leaves intensive treatment. Participants will try this treatment virtually to assess its impact on recovery and relapse prevention. Suitable candidates have recently been discharged from an intensive treatment program and have a history of anorexia nervosa or a similar condition. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance recovery strategies for anorexia nervosa.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that the Facing Eating Disorder Fears Condition is safe for treating anorexia nervosa?
Research shows that exposure therapy, a component of the Facing Eating Disorder Fears (FED-F) treatment, can be safe for patients. Previous studies have helped people confront their fears and reduce anxiety. For eating disorders, exposure therapy often involves gradually facing fears related to food and body image.
A review of studies found that many patients handle exposure therapy well, and it can lead to less dissatisfaction with their bodies when combined with cognitive-behavioral therapy (CBT). This suggests that FED-F, which combines exposure therapy with education about the disorder and cognitive skills, may also be well-received.
No specific negative effects have been reported for FED-F, likely because it focuses on psychological methods rather than medication. However, since this is a new approach specifically for anorexia nervosa, ongoing studies will continue to assess its safety and effectiveness.
Overall, evidence suggests that FED-F could be a safe option for those looking to address fears associated with anorexia nervosa.12345Why are researchers excited about this trial?
Researchers are excited about the "Facing Eating Disorder Fears Condition" trial because it offers a fresh approach to treating anorexia nervosa. Unlike standard treatments that often rely on in-person therapy and nutritional counseling, this method incorporates virtual treatment sessions, making it more accessible and flexible for participants. Additionally, the integration of mobile assessments allows for real-time tracking of progress and personalization of care, which could lead to more effective and timely interventions. This innovative approach has the potential to make treatment more engaging and responsive to individual needs.
What evidence suggests that the FED-F treatment could be effective for anorexia nervosa?
Research has shown that the Facing Eating Disorder Fears treatment (FED-F), which participants in this trial may receive, helps people with anorexia nervosa by reducing their fears and avoidance behaviors. This method combines exposure therapy with education and cognitive skills to address fears about food, weight gain, and social situations. Early results suggest that targeting these primary fears can lead to better outcomes for those with eating disorders. Studies indicate that reducing these fears may improve eating habits and decrease the chances of relapse. This treatment is designed as an accessible online option for those seeking help with anorexia nervosa.12467
Who Is on the Research Team?
Cheri A Levinson, Ph.D.
Principal Investigator
University of Louisville
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 who have been diagnosed with Anorexia Nervosa (AN) or are in partial/full remission from AN, and have been discharged from intensive care like inpatient or residential treatment within the last 6 months. It's not suitable for individuals under 18, over 65, those with severe suicidal thoughts, extremely low weight, psychosis, mania, or who don't meet the criteria for AN.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase I: Refinement and Feasibility Testing
Refine FED-F into a fully virtual format with input from patients and stakeholders and collect preliminary data on its feasibility and acceptability
Phase II: Pilot RCT
Conduct a small pilot RCT of FED-F as compared to treatment as usual (TAU)
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Facing Eating Disorder Fears Condition
Facing Eating Disorder Fears Condition is already approved in United States for the following indications:
- Anorexia Nervosa
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator